跳至主要内容
临床试验/NCT00515658
NCT00515658Unknown2 期

Antidepressant Effect of Theta-Burst rTMS

Rambam Health Care Campus2 个研究点 分布在 1 个国家开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
2 期
试验地点
2

研究概览

简要总结

The aim of this study is to evaluate the safety and efficacy of theta-burst rTMS in patients with major depression. Patients will be randomized to receive ether left-sided intermittent theta-burst rTMS or rigt-sided continuous theta-burst rTMS or sham theta-burst rTMS over two weeks period with an option for an additional two weeks period, depending on treatment response. Clinical assessments will be performed weekly by the Hamilton depression rating scale. In addition, standard neurophysiological assessment of cortical excitability will be done.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major depressive episode (DSM IV criteria).
  • Informed consent.
  • Age: 18-70.

排除标准

  • Suicidality
  • Psychosis
  • Pacemaker
  • Cardiac arrythmia
  • seizure disorder
  • implantable metal devices
  • PNS and CNS disorders
  • any other contraindications as specified in safety guidelines for rTMS (Wassermenn, 1998).

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验